Shinhung Co., Ltd (KRX:004080)
13,440
-140 (-1.03%)
Jun 4, 2026, 12:32 PM KST
Shinhung Revenue
Shinhung had revenue of 25.15B KRW in the quarter ending March 31, 2026, with 6.52% growth. This brings the company's revenue in the last twelve months to 104.15B, up 5.07% year-over-year. In the year 2025, Shinhung had annual revenue of 102.61B with 0.84% growth.
Revenue (ttm)
104.15B
Revenue Growth
+5.07%
P/S Ratio
1.21
Revenue / Employee
520.73M
Employees
200
Market Cap
126.13B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 102.61B | 851.32M | 0.84% |
| Dec 31, 2024 | 101.76B | -10.69B | -9.50% |
| Dec 31, 2023 | 112.44B | -5.73B | -4.85% |
| Dec 31, 2022 | 118.18B | -8.68B | -6.84% |
| Dec 31, 2021 | 126.85B | 10.20B | 8.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SD Biosensor | 718.78B |
| Value Added Technology | 430.30B |
| CLASSYS | 346.88B |
| Vieworks | 243.11B |
| T&L Co., Ltd. | 157.91B |
| BioNote | 122.44B |
| Dongbang Medical | 117.37B |
| PCL, Inc. | 4.98B |